Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease
暂无分享,去创建一个
W. Rosenberg | J. Parkes | S. Tanwar | E. Tsochatzis | E. Pizzo | J. O’Beirne | K. Sennett | Ankur Srivastava | Simcha Jong | A. Gola | R. Gailer | S. Morgan | A. Srivastava